Canopy Growth Corporation (WEED.TO)
CAD 4.07
(-7.08%)
CAD 4.07
(-7.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 80.88 Million CAD | 177.67% |
| 2022 | -104.14 Million CAD | 46.06% |
| 2021 | -193.05 Million CAD | -388.31% |
| 2020 | 66.96 Million CAD | 311.34% |
| 2019 | -31.68 Million CAD | -135.63% |
| 2018 | 88.93 Million CAD | 19.86% |
| 2017 | 74.19 Million CAD | 97.15% |
| 2016 | 37.63 Million CAD | 98.21% |
| 2015 | 18.98 Million CAD | 4482.13% |
| 2014 | 414.34 Thousand CAD | 0.0% |
| 2013 | - CAD | -100.0% |
| 2012 | 4144.00 CAD | 0.0% |
| 2011 | - CAD | -100.0% |
| 2010 | 4488.00 CAD | 717.49% |
| 2009 | 549.00 CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 16.99 Million CAD | 178.59% |
| 2023 Q1 | 5.93 Million CAD | 106.56% |
| 2023 Q2 | 23.42 Million CAD | 294.58% |
| 2023 Q3 | 28.22 Million CAD | 20.49% |
| 2023 Q4 | 8.26 Million CAD | -70.71% |
| 2023 FY | 80.88 Million CAD | 177.67% |
| 2022 Q2 | 3.82 Million CAD | 374.5% |
| 2022 Q1 | -1.39 Million CAD | 99.13% |
| 2022 Q3 | -2.44 Million CAD | -163.88% |
| 2022 Q4 | -90.5 Million CAD | -3607.66% |
| 2022 FY | -104.14 Million CAD | 46.06% |
| 2021 Q2 | -71.14 Million CAD | -361.18% |
| 2021 FY | -193.05 Million CAD | -388.31% |
| 2021 Q1 | 27.23 Million CAD | 177.94% |
| 2021 Q3 | 10.09 Million CAD | 114.18% |
| 2021 Q4 | -159.24 Million CAD | -1678.22% |
| 2020 Q3 | 24.58 Million CAD | -5.73% |
| 2020 Q1 | 6.49 Million CAD | 103.16% |
| 2020 Q2 | 26.08 Million CAD | 301.54% |
| 2020 FY | 66.96 Million CAD | 311.34% |
| 2020 Q4 | 9.8 Million CAD | -60.14% |
| 2019 Q4 | -205.62 Million CAD | -441.41% |
| 2019 Q1 | 106.05 Million CAD | 54.88% |
| 2019 Q2 | 3.52 Million CAD | -96.68% |
| 2019 Q3 | 60.22 Million CAD | 1609.59% |
| 2019 FY | -31.68 Million CAD | -135.63% |
| 2018 Q2 | -33.98 Million CAD | -180.94% |
| 2018 Q4 | 68.47 Million CAD | 449.93% |
| 2018 Q3 | 12.45 Million CAD | 136.64% |
| 2018 Q1 | 41.98 Million CAD | 484.99% |
| 2018 FY | 88.93 Million CAD | 19.86% |
| 2017 Q2 | 28.75 Million CAD | 45.98% |
| 2017 Q3 | 18.57 Million CAD | -35.41% |
| 2017 FY | 74.19 Million CAD | 97.15% |
| 2017 Q1 | 19.69 Million CAD | 1289.91% |
| 2017 Q4 | 7.17 Million CAD | -61.35% |
| 2016 FY | 37.63 Million CAD | 98.21% |
| 2016 Q4 | 1.41 Million CAD | -91.64% |
| 2016 Q3 | 16.94 Million CAD | 7.05% |
| 2016 Q2 | 15.82 Million CAD | 359.42% |
| 2016 Q1 | 3.44 Million CAD | 28.16% |
| 2015 FY | 18.98 Million CAD | 4482.13% |
| 2015 Q3 | 2.75 Million CAD | -70.83% |
| 2015 Q4 | 2.68 Million CAD | -2.47% |
| 2015 Q2 | 9.44 Million CAD | 130.73% |
| 2015 Q1 | 4.09 Million CAD | 1783.64% |
| 2014 Q4 | -243.2 Thousand CAD | -205.47% |
| 2014 FY | 414.34 Thousand CAD | 0.0% |
| 2014 Q1 | 109.77 Thousand CAD | 177.64% |
| 2014 Q3 | 230.59 Thousand CAD | 209.62% |
| 2014 Q2 | 74.47 Thousand CAD | -32.16% |
| 2013 Q4 | -141.39 Thousand CAD | -294668.75% |
| 2013 FY | - CAD | -100.0% |
| 2013 Q1 | 998.00 CAD | 3.42% |
| 2013 Q2 | 997.00 CAD | -0.1% |
| 2013 Q3 | 48.00 CAD | -95.19% |
| 2012 Q3 | 1002.00 CAD | 0.0% |
| 2012 FY | 4144.00 CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | 965.00 CAD | -3.69% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | 1185.00 CAD | -4.97% |
| 2011 Q1 | 1247.00 CAD | 3.31% |
| 2011 Q2 | 1247.00 CAD | 0.0% |
| 2011 Q4 | - CAD | -100.0% |
| 2011 FY | - CAD | -100.0% |
| 2010 Q1 | 549.00 CAD | 0.0% |
| 2010 Q4 | 1207.00 CAD | -18.72% |
| 2010 FY | 4488.00 CAD | 717.49% |
| 2010 Q3 | 1485.00 CAD | 0.0% |
| 2010 Q2 | - CAD | -100.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | 549.00 CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aurora Cannabis Inc. | 131.46 Million CAD | 38.474% |
| Avicanna Inc. | 6.65 Million CAD | -1114.683% |
| Avant Brands Inc. | 12.43 Million CAD | -550.595% |
| Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 32667.091% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | -680.413% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 47.015% |
| MediPharm Labs Corp. | 5.85 Million CAD | -1281.418% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | -130.609% |
| Willow Biosciences Inc. | -659 Thousand CAD | 12373.445% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | -280.138% |